MLchartDataset catalogue

fostriecin

Term · Oncology and biomedicine · MLC-T-ONC-013770

An anti-tumor antibiotic isolated from the bacterium Streptomyces pulveraceus. Fostriecin inhibits topoisomerase II catalytic activity, resulting in protein-associated strand breaks and impaired DNA and RNA synthesis in various malignant cell types. This agent also inhibits serine/threonine protein phosphatase type 2A in some tumor cell types, thereby interfering with cellular proliferation and differentiation.

Table 1. Record
IdentifierMLC-T-ONC-013770
FieldOncology and biomedicine
AbbreviationFST
Synonymsphosphotrienin
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-013770",
  "term": "fostriecin",
  "field": "Oncology and biomedicine",
  "definition": "An anti-tumor antibiotic isolated from the bacterium Streptomyces pulveraceus. Fostriecin inhibits topoisomerase II catalytic activity, resulting in protein-associated strand breaks and impaired DNA and RNA synthesis in various malignant cell types. This agent also inhibits serine/threonine protein phosphatase type 2A in some tumor cell types, thereby interfering with cellular proliferation and differentiation.",
  "abbreviation": "FST",
  "synonyms": [
    "phosphotrienin"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/fostriecin/"
}

Record 7,591 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.